Liver Pathology: Translating a World of Colors into Clinically Relevant Pathology Reports

Liver Pathology: Translating a World of Colors into Clinically Relevant Pathology Reports is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Jan 24 - 26, 2019 at USCAP West, Palm Springs, California, United States of America. This CME Conference has been approved for a maximum of 17 AMA PRA Category 1 Credits and 17 SAM Credit Hours.

Conference Description :
The microscopic pattern of liver biopsies for non-neoplastic diseases has changed with increasing emphasis on steatohepatitis, fibrosis regression and drug-induced liver disease. The reasons for these changes (based on consultative cases at several large medical centers) include classification of an hepatic pattern of injury, primary biliary cholangitis, fatty liver disease, autoimmune hepatitis, etiology of cirrhosis and transplant pathology (unpublished data). Among the neoplastic cases, hepatocellular carcinoma, cholangiocarcinoma/metastatic adenocarcinoma and hepatocellular adenoma are the leading areas that cause problems in diagnosis for practicing pathologists. Advances in radiologic techniques facilitate targeting smaller lesions, necessitating judicious use of immunohistochemistry. In the last few years, characteristic molecular changes have been described in a variety of liver tumors and are increasingly being used for diagnosis. Take advantage of this fantastic mentoring opportunity to study liver interactively with experts who can improve your performance and enhance your practice.

Conference Objectives are :
• Formulate pattern diagnosis for hepatitis and biliary diseases, and narrow the differential diagnosis based on clinical features.
• Recognize liver infections and common features of liver involvement in systemic diseases.
• Obtain appropriate immunohistochemical stains for focal nodular hyperplasia, hepatocellular adenoma and hepatocellular carcinoma.
• Distinguish benign and malignant biliary proliferations on biopsies and frozen sections.

Additional details will be posted as soon as they are available.